A detailed history of Amundi transactions in Moderna, Inc. stock. As of the latest transaction made, Amundi holds 671,000 shares of MRNA stock, worth $24.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
671,000
Previous 735,429 8.76%
Holding current value
$24.7 Million
Previous $87.3 Million 48.65%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $4.1 Million - $8.06 Million
-64,429 Reduced 8.76%
671,000 $44.8 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $8.89 Million - $14.6 Million
87,840 Added 13.56%
735,429 $87.3 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $9.12 Million - $12.3 Million
-106,771 Reduced 14.15%
647,589 $69 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $13.1 Million - $19.6 Million
187,810 Added 33.15%
754,360 $75 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $172,381 - $226,378
1,788 Added 0.32%
566,550 $58.5 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $17.5 Million - $23.8 Million
-148,048 Reduced 20.77%
564,762 $68.6 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $12.8 Million - $18.6 Million
-94,499 Reduced 11.71%
712,810 $109 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $7.93 Million - $14.1 Million
67,000 Added 9.05%
807,309 $145 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $52.9 Million - $86.9 Million
447,693 Added 153.0%
740,309 $93 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $8 Million - $12.1 Million
68,334 Added 30.47%
292,616 $46.8 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $39 Million - $72.5 Million
-308,463 Reduced 57.9%
224,282 $35.7 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $12.5 Million - $20.4 Million
55,228 Added 11.57%
532,745 $112 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $7.32 Million - $16 Million
32,977 Added 7.42%
477,517 $184 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $57.8 Million - $104 Million
444,540 New
444,540 $104 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.